Azetidine compounds as orexin receptor antagonists

Details for Australian Patent Application No. 2007285371 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Gude, Markus; Aissaoui, Hamed; Koberstein, Ralf; Boss, Christoph; Sifferlen, Thierry

Agent A J Park

Pub. Number AU-A-2007285371

PCT Pub. Number WO2008/020405

Priority PCT/ IB2006/052814 15.08.06 IB

Filing date 15 August 2007

Wipo publication date 21 February 2008

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 515/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/020405 Priority application(s): WO2008/020405

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007285379-Stabilised packaging container

2007285361-Utensil for cracking, opening and separating an egg